Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hirao, T. Saraya, D. Kurai, H. Wada, H. Ishii, S. Kurata, H. Taguchi, S. Kamiya, T. Akashi, K. Nakagaki, K. Nakata, H. Goto (Tokyo, Saitama, Niigata, Japan). Comparison of immunomodulating effects among clarithromycin, dexamethasone and levofloxacin on the murine model of mycoplasma pneumoniae pneumonia. Eur Respir J 2008; 32: Suppl. 52, 3687

Member's Comments

No comment yet.

Related content which might interest you: Immunomodulating effect of clarithromycin in a murine model of mycoplasma pneumoniae pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 737s Year: 2007 Co-treatment with clarithromycin and dexamethasone on murine mycoplasma pneumoniae pneumonia model Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Comparison of conventional and sequential antibiotic therapy of community-acquired pneumonia with levofloxacin and moxifloxacin Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Therapeutic efficacy of macrolides, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection in which Streptococcus pyogenes was isolated in sputum culture Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Efficacy and safety of azithromycin vs. clarithromycin for the treatment of community-acquired pneumonia due to legionella pneumophila Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections Source: Eur Respir J 2002; 20: 3S-8S Year: 2002 Telavancin vs. linezolid in an animal model of severe MRSA pneumonia Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis Source: Eur Respir J 2014; 44: 808-811 Year: 2014 Anti-inflammatory properties of nimesulide and clarithromycin: a comparative study during the therapy of bronchial sepsis involving P.aeruginosa Source: Eur Respir J 2002; 20: Suppl. 38, 373s Year: 2002 Eradication treatment in Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) on patients with pseudomonas aeruginosa Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017 Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus, but selects for macrolide resistance in Danish CF-patients Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 In vitro activity of moxifloxacin and linezolid against mycobacteria Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Comparison of moxifloxacin and ofloxacin in treatment of multidrug resistant pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002 Safety and efficacy of linezolid, clarithromycin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Antipyretic effect of dexamethasone in community-acquired pneumonia Source: Eur Respir J 2015; 46: 570-573 Year: 2015